be 2254 has been researched along with Adenoma, Prostatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foglar, R; Hirasawa, A; Horie, K; Shibata, K; Tsujimoto, G | 1 |
1 other study(ies) available for be 2254 and Adenoma, Prostatic
| Article | Year |
|---|---|
Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cricetinae; DNA; Humans; Male; Phenethylamines; Plasmids; Prostatic Hyperplasia; Radioligand Assay; Rats; Recombinant Proteins; Tetralones; Transfection | 1995 |